Clinical Oncology
Volume 18, Issue 6 , Pages 453-458, August 2006

Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

  • M.J. Beresford

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • Corresponding Author InformationAuthor for correspondence: Mark Beresford, Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, Middlesex HA6 2RN, UK. Tel: +44-1923-826111.
    • ,
  • R. Burcombe

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • M.-L. Ah-See

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK
    • ,
  • D. Stott

      Affiliations

    • Health Research Development and Support Unit (HRDSU), University of Hertfordshire, Hatfield, UK
    • ,
  • A. Makris

      Affiliations

    • Mount Vernon Cancer Centre, Northwood, UK

Received 13 December 2005; received in revised form 22 March 2006; accepted 10 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(06)00161-0

doi:10.1016/j.clon.2006.04.006

Clinical Oncology
Volume 18, Issue 6 , Pages 453-458, August 2006

Article Tools

* Image Usage & Resolution